A Beautiful Cause, and a Big Goal

If you know the RevitaLash® Cosmetics story, you know that philanthropy is woven into our DNA. Our founder, Michael Brinkenhoff, M.D., famously created the original lash serum for his beloved wife, Gayle to help her feel more beautiful during her brave battle with breast cancer.

Today, we honor Gayle’s legacy with our Eternally Pink® pledge, which assures a portion of proceeds from every product sold gives back to breast cancer initiatives. We directly fund important research and support those affected by breast cancer – all thanks to you, our RLC community.

ROAD TO $10 MILLION

We’ve made $9 million+ in donations, investments, and in-kind contributions to breast cancer initiatives since 2008. Together, we can reach the next milestone.

Why Breast Cancer Awareness Matters

Breast cancer is the most common cancer in women in the United States (except for skin cancers). In 2025, an estimated 300,000+ new cases will be diagnosed, and 42,000 women will die from breast cancer. One in eight U.S. women will develop breast cancer in her lifetime.* The numbers are even larger worldwide. In 2022, 2.3 million women around the globe were diagnosed with breast cancer. Breast cancer affects women (and men) in every country in the world.†

Breast cancer can have an impact on every part of a patient’s life, from her physical health, her relationships, and her work to her self-image. This is why we support both quality-of-life care for those affected by breast cancer, as well as research that brings us closer to a world without this devastating disease.

How We Give Back with Your Help

If you’ve seen the pink ribbon on our packaging, you might know that we dedicate a portion of the proceeds from every RevitaLash® Cosmetics product sold to breast cancer initiatives. But what does that look like in practice?

Here’s a look at a few of the impactful projects we’ve funded so far in 2025:

Funding Research

With our partner Future Dreams, we’re funding a potentially groundbreaking study of Triple-Negative Breast Cancer at the world-renowned Francis Crick Institute in London.

The Breast TRACERx (TRAcking Cancer Evolution through Therapy (Rx)) project is a collaboration between world-renowned research institutes in the UK and France, including the Francis Crick Institute, which aims to explore the extent and causes of cell-to-cell diversity (intratumor heterogeneity) and drivers of this variability, such as chromosomal instability (CIN).

To this end, Breast TRACERx, a prospective multicenter study combining two clinical trials (TRACERx-TNBC and SCANADRE), has recruited 142 patients with Triple-Negative Breast Cancer (TNBC) from whom multi-region tumor samples were obtained for DNA/RNA sequencing across multiple clinically relevant timepoints: pre-treatment, surgery, and in instances of relapse. Using this valuable resource, researchers are studying how TNBC evolves, aiming to identify specific genetic changes that may lead to relapse and investigating mechanisms by which tumors may evade the body’s immune defenses to provide a comprehensive view of tumor evolution.

Supporting Community

In addition to sponsoring potentially groundbreaking research, our partnership with Future Dreams will fund programs at Future Dreams House in London. Future Dreams House is the only dedicated breast cancer support center in the UK offering in person and online support.

RevitaLash® Cosmetics is also the headline sponsor for one of Future Dreams’ biggest fundraising event this year, a fashion show taking place on May 8th featuring more than 30 breast cancer survivors and thrivers as models.

The event will raise funds for community support, breast health awareness, and research. Additionally, our partnership will support workshops and classes for breast cancer patients, as well as RevitaLash® Cosmetics products for Future Dreams House service users.

Caring for Patients

We recently renewed our commitment to cancer patients in California with a two-year, $100,000 grant for the Cold Cap Program through Ridley-Tree Cancer Center and UCLA Medical Center in Santa Barbara. This initiative, in partnership with the Cancer Foundation of Santa Barbara, aims to provide vital support to cancer patients undergoing chemotherapy treatment.

The grant enables the program to offer specialized scalp-cooling caps to eligible cancer patients, helping them retain their hair during chemotherapy. The innovative Paxman system, renowned globally for its effectiveness, has assisted over 100,000 patients in more than 50 countries.

The Cold Cap system, designed for use during chemotherapy, protects hair follicles, helping to prevent hair loss on the head. The treatment helps patients not only retain their hair, but also their confidence and sense of self during a difficult time. These are just a few of the impactful projects we’ve undertaken recently. There’s much more in the works for 2025!

The Road to $10 Million

Reaching our next milestone will enable us to make an even bigger difference in the lives of people affected by breast cancer – not only here in the U.S., but around the globe.

With the help of our RevitaLash® Cosmetics community, team, and global partners, we can accomplish more than we ever thought possible. We invite you to join us on our journey to making a positive difference in the fight against breast cancer – and our personal mission to find a cure.

*Source: American Cancer Society.
†Source: World Health Organization.